Narjust Florez, MD, FASCO

Narjust Florez, MD, FASCO, is associate medical director of the Cancer Care Access Program, codirector of the Young Lung Cancer Program, and a thoracic medical oncologist at Dana-Farber Cancer Institute. She is also an assistant professor of medicine at Harvard Medical School.

Dr Florez completed her internal medicine residency at Rutgers New Jersey Medical School and a fellowship at Mayo Clinic in Rochester, MN, where she was the chief fellow from 2018 to 2019.

Her clinical interests include targeted therapy for lung cancer and the care of women with lung cancer, including their unique aspects of cancer survivorship. Dr Florez is the principal investigator of the SHAWL study, the largest study to date evaluating sexual dysfunction in women with lung cancer.

Apart from her clinical interests in lung cancer, she is also a leading and productive researcher in cancer health disparities and gender and racial discrimination in medical education and medicine. Dr Florez has received several awards, including the 2018 National Hispanic Medical Association Resident of the Year Award, the 2019 Mayo Brothers Distinguished Fellowship Award, and the 2020 Rising Star Award from the LEAD National Conference for women in hematology and oncology.

In addition, Dr Florez founded the Florez Lab at Dana-Farber Cancer Institute in 2019. This laboratory focuses on lung cancer, social justice issues in medicine, and medical education. Its long-term goal is to create a welcoming environment for medical trainees from historically underrepresented groups in medicine while improving the care of vulnerable populations. Members of the Florez Lab are agents of change.